About the authors

Mario Lacouture MD

Mario Lacouture, MD, is director of the Oncodermatology Program at Memorial Sloan Kettering Cancer Center and specializes in the dermatologic side effects of cancer treatment. He is the founder of the SERIES (Skin and Eye Reactions to Inhibitors of EGFR and kinases) Clinic, an interdisciplinary program bringing together patient care, education, and research, and is co-chair of the Skin Toxicity Study Group of the Multinational Association of Supportive Care in Cancer. IASLC Lung Cancer News spoke with him about skin conditions frequently seen in patients with cancer who are receiving immunothe

Related Articles